what is glp 1 supposed to do GLP-1 Meds: They Really and What They Don't Should I take a GLP-1

Affected individuals are typically characterised by lipoatrophic diabetes, insulin resistance and hepatic steatosis ( Agonists of the glucagon-like peptide-1 receptor (GLP-1R) deliver significant beneficial effects both in treating type 2 diabetes and obesity ( Reports of the effects of GLP-1R agonists in individuals with inherited lipodystrophies are currently limited to only 3 case studies, and these examine FPLD but not CGL patients ( Here we used a well validated Bscl2 -null (seipin knockout) mouse model of CGL type 2 (CGL2) to examine the effectiveness of a GLP-1R agonist, in treating lipoatrophic diabetes, hepatic steatosis and hyperphagia in CGL to inform the adoption of this class of drugs for individuals with lipodystrophy

Are at risk for or have been diagnosed with heart disease

Ozempic and Wegovy are injectable forms that showed no detectable levels in breast milk in recent studies

Decreases food-related reward sensations, making it easier to resist cravings 2

Perlis, L

There is still an unnecessary stigma surrounding medical weight loss that many are trying to navigate